Differential mutagenicity of riddelliine in liver endothelial and parenchymal cells of transgenic big blue rats
- 25 November 2004
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 215 (2) , 151-158
- https://doi.org/10.1016/j.canlet.2004.06.013
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Mutations Induced by the Carcinogenic Pyrrolizidine Alkaloid Riddelliine in the Liver cII Gene of Transgenic Big Blue RatsChemical Research in Toxicology, 2004
- Pyrrolizidine Alkaloids—Genotoxicity, Metabolism Enzymes, Metabolic Activation, and MechanismsDrug Metabolism Reviews, 2004
- Toxicity and carcinogenicity of riddelliine in rats and miceToxicology Letters, 2003
- Correlation of DNA adduct formation and riddelliine-induced liver tumorigenesis in F344 rats and B6C3F1 miceCancer Letters, 2003
- Human Liver Microsomal Metabolism and DNA Adduct Formation of the Tumorigenic Pyrrolizidine Alkaloid, RiddelliineChemical Research in Toxicology, 2002
- The Hepatic Endothelial Carcinogen Riddelliine Induces Endothelial Apoptosis, Mitosis, S Phase, and p53 and Hepatocytic Vascular Endothelial Growth Factor Expression after Short-Term ExposureToxicology and Applied Pharmacology, 2002
- Epithelial and fibroblast cell lines cultured from the transgenic BigBlue™ rat: an in vitro mutagenesis assayMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2001
- Metabolic Activation of the Tumorigenic Pyrrolizidine Alkaloid, Riddelliine, Leading to DNA Adduct Formation in VivoChemical Research in Toxicology, 2000
- Somatic mutation in the mammary gland: influence of time and estrusMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1999
- Toxicity and carcinogenicity of riddelliine following 13 weeks of treatment to rats and miceToxicon, 1994